A carregar...

Pharmacometabolomic signature links simvastatin therapy and insulin resistance

INTRODUCTION: Statins, widely prescribed drugs for treatment of cardiovascular disease, inhibit the biosynthesis of low density lipoprotein cholesterol (LDL-C). Despite providing major benefits, sub populations of patients experience adverse effects, including muscle myopathy and development of type...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Metabolomics
Main Authors: Elbadawi-Sidhu, Mona, Baillie, Rebecca A., Zhu, Hongjie, Chen, Yii-Der Ida, Goodarzi, Mark O., Rotter, Jerome I., Krauss, Ronald M., Fiehn, Oliver, Kaddurah-Daouk, Rima
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5931366/
https://ncbi.nlm.nih.gov/pubmed/29732238
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!